Post-earnings recap
Reported
Wed, Apr 24, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The earnings report showed that Novartis met expectations with its EPS, but no revenue figures were provided. The stock reacted positively, gaining 2.53%, likely due to the overall sentiment around the company's ongoing focus on innovation. Investors may be encouraged by management's commitment to its therapeutic areas despite the lack of specific guidance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.33 | N/A | N/A |
Management emphasized their commitment to innovation and maintaining a strong pipeline. They did not provide specific forward-looking guidance.
Management did not provide specific guidance for the upcoming quarters.
The company remains focused on its core therapeutic areas.